Showing results (1961-1970 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|September 28, 2018
CD19+ tumor-infiltrating B-cells prime CD4+ T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancerQi Jiang, Qiang Fu, Yuan Chang, et al.
Cancer Immunology, Immunotherapy : CII|September 12, 2018
Oncogenic MYD88 mutations in lymphoma: novel insights and therapeutic possibilitiesAlexander N R Weber, Yamel Cardona Gloria, Özcan Çınar, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 2018
Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancerJohn Wahba, Marina Natoli, Lynsey M Whilding, et al.
Cancer Immunology, Immunotherapy : CII|October 11, 2018
Opposing roles of eosinophils in cancerSonja C S Simon, Jochen Utikal, Viktor Umansky
Cancer Immunology, Immunotherapy : CII|March 3, 2022
Fc-independent functions of anti-CTLA-4 antibodies contribute to anti-tumor efficacyYosuke Sato, Cierra N Casson, Atsushi Matsuda, et al.
Cancer Immunology, Immunotherapy : CII|March 9, 2022
Elotuzumab, a potential therapeutic humanized anti-SLAMF7 monoclonal antibody, enhances natural killer cell-mediated killing of primary effusion lymphoma cellsJutatip Panaampon, Ryusho Kariya, Seiji Okada
Cancer Immunology, Immunotherapy : CII|May 30, 2018
Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective studyMarie-Léa Gauci, Philippe Boudou, Barouyr Baroudjian, et al.
Cancer Immunology, Immunotherapy : CII|May 30, 2018
Merkel cell carcinoma and cellular cytotoxicity: sensitivity to cellular lysis and screening for potential target antigens suitable for antibody-dependent cellular cytotoxicityJocelyn Ollier, Thibault Kervarrec, Mahtab Samimi, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 1999
A tandem repeat of MUC1 core protein induces a weak in vitro immune response in human B cellsE Andersson, P Henderikx, E Krambovitis, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 1999
Increased generation of autologous tumor-reactive lymphocytes by anti-CD3 monoclonal antibody and prothymosin alphaC N Baxevanis, G Spanakos, I F Voutsas, et al.
Pageof 652